Maravai LifeSciences Announces March 2023 Investor Conference Schedule
March 08 2023 - 8:00AM
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of
life science reagents and services to researchers and biotech
innovators, is scheduled to participate in the following investor
conferences during the month of March.
On March 15, 2023, at 2:00 p.m. PST, Kevin Herde, Chief
Financial Officer, and Deborah Barbara, Vice President, Strategy
and Business Development will participate in a fireside chat at the
Barclays Global Healthcare Conference being held in Miami,
Florida.
On March 21, 2023, at 9:45 a.m. PST, Carl Hull, Chairman of the
Board and Interim CEO will participate in a fireside chat at the
KeyBanc Capital Markets Life Sciences and MedTech Investor Forum
being held virtually.
A live webcast of the presentations will be available to all
interested parties on the Maravai LifeSciences Investor Relations
website, under News & Events. An archived version of the
webcasts will also be available on the Maravai website following
the completion of each event.
About Maravai
Maravai is a leading life sciences company providing critical
products to enable the development of drug therapies, diagnostics,
and novel vaccines and to support research on human diseases.
Maravai’s companies are leaders in providing products and services
in the fields of nucleic acid synthesis and biologics safety
testing to many of the world’s leading biopharmaceutical, vaccine,
diagnostics, and cell and gene therapies companies.
For more information about Maravai LifeSciences, visit
www.maravai.com.
Contact Information:
Media Contact:
Sara Michelmore
MacDougall Advisors
+1 781-235-3060
maravai@macdougall.bio
Investor Contact:
Deb Hart
Maravai LifeSciences
+1 858-988-5917
ir@maravai.com
Maravai LifeSciences (NASDAQ:MRVI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Maravai LifeSciences (NASDAQ:MRVI)
Historical Stock Chart
From Apr 2023 to Apr 2024